Psoriasis

August is Psoriasis Action Month. This year, the National Psoriasis Foundation (NPF) is dedicated to helping people living with psoriasis take control of their disease. For more information about the NPF...

In a recent study, researchers sough to explore the characteristics of patients with PsA with and without axial involvement.

Researchers investigated whether anti-tumor necrosis factor agents were associated with an increased risk for psoriasiform diseases among patients with inflammatory bowel diseases.

Results from a recent study highlight the prevalence of psoriatic arthritis among patients with psoriasis.

In a new set of recommendations, the National Psoriasis Foundation Medical Board has addressed the impact of diet on psoriasis and psoriatic arthritis.

In a recent study, researchers investigated the effects of long-term methotrexate use on the risk of chronic viral hepatitis-related cirrhosis among patients with psoriasis.

Researchers examined the safety and efficacy of a monoclonal antibody through 3 years of use in patients with moderate to severe plaque psoriasis.

The US Food and Drug Administration has approved expanding the label of a psoriasis drug to include adults with moderate-to-severe plaque psoriasis.

The FDA has approved a label update for a biologic used for the treatment of adult patients with moderate-to-severe plaque psoriasis

After a separate study indicated that an immunosuppressive drug used for the treatment of psoriasis reduced aortic inflammation, researchers investigated whether another common psoriasis treatment could...